Prediabetes

Audience: Patients and providers
Status: Clinical guide · patient + provider
Last updated: 2026-03-27

1. Clinical overview

Prediabetes is dysglycemia below the threshold for type 2 diabetes but above normal range, and it should be treated as a high-risk metabolic warning state rather than a benign lab finding.

2. Common causes and risk factors

Excess adiposity, insulin resistance, family history, prior gestational diabetes, sleep disruption, and low activity are common drivers.
Hypertension, dyslipidemia, fatty liver, and OSA often coexist.

3. Typical symptoms

Most patients are asymptomatic; risk is identified through screening and associated metabolic findings.

4. Diagnosis and evaluation

Use A1c, fasting glucose, or 2-hour OGTT according to the clinical scenario.
Review weight trajectory, medication contributors, pregnancy history, and cardiometabolic risk profile.
Distinguish prediabetes from overt diabetes when symptoms or rising trends suggest progression.

5. Treatment (non-pharmacologic)

Weight reduction, nutrition quality improvement, regular activity, sleep optimization, and stress reduction are the foundation.
Counseling should frame the goal as diabetes prevention plus broader cardiometabolic protection.

6. Treatment (pharmacologic)

Metformin is the most common medication option in higher-risk prediabetes, especially with rising A1c, BMI 35 or greater, younger age, or prior gestational diabetes.
Obesity-focused medications such as semaglutide, tirzepatide, phentermine/topiramate ER, or naltrexone/bupropion ER may be useful when weight is a major driver and access allows.
Medication decisions should still be aligned with overall metabolic risk, blood pressure, lipids, and fatty-liver context rather than glucose in isolation.

7. Monitoring and follow-up

Recheck glycemic markers every 3 to 6 months during active intervention.
Track BP, lipids, renal function, weight, and development of diabetes symptoms.

8. Practical counseling points

Prediabetes is reversible in many patients, but it requires active follow-up rather than a one-time warning.
Use realistic targets such as 5 to 10 percent weight loss and weekly movement goals.
Address food insecurity, shift work, and other barriers directly when present.

9. Red flags and escalation

Escalate evaluation when glycemic markers rise quickly, classic diabetes symptoms appear, or cardiorenal risk accelerates.
Consider endocrine referral for atypical progression or diagnostic uncertainty.

10. Guideline references

American Diabetes Association Standards of Care.
CDC Diabetes Prevention Program frameworks.
Obesity and cardiometabolic prevention guidance where relevant.

Note: Educational guide only; not a substitute for individualized medical care.